Literature DB >> 15985017

Age-specific antibody to hepatitis E virus has remained constant during the past 20 years in Japan.

E Tanaka1, A Matsumoto, N Takeda, T-C Li, T Umemura, K Yoshizawa, Y Miyakawa, T Miyamura, K Kiyosawa.   

Abstract

We investigated the presence of antibodies to hepatitis E virus (anti-HEV) and hepatitis A virus (anti-HAV) by enzyme immunoassays in sera from 1015 individuals collected in 1974, 1984 and 1994. Age-specific profiles of anti-HEV remained unchanged with a peak at 40-49 years, while those of anti-HAV started to increase in individuals aged 20-29 years in 1974, 30-39 years in 1984 and 40-49 years in 1994. These results suggest that a silent HEV infection has been taking place in the last 20 years or so in Japan, while HAV infection has been terminated at least since 1974.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15985017     DOI： 10.1111/j.1365-2893.2005.00616.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN： 1352-0504            Impact factor:   3.728


  10 in total

1.  Prevalence of hepatitis E virus infection in children in the northeast of Spain.

Authors:  Maria Buti; Pere Plans; Angela Domínguez; Rossend Jardi; Francisco Rodriguez Frias; Rafael Esteban; Luis Salleras; Antoni Plasencia
Journal:  Clin Vaccine Immunol       Date:  2008-03-05

2.  Time trend of the prevalence of hepatitis E antibodies among farmers and blood donors: a potential zoonosis in Denmark.

Authors:  Peer B Christensen; Ronald E Engle; Charlotte Hjort; Keld M Homburg; Werner Vach; Jørgen Georgsen; Robert H Purcell
Journal:  Clin Infect Dis       Date:  2008-10-15       Impact factor: 9.079

3.  The mystery of hepatitis E seroprevalence in developed countries: is there subclinical infection due to hepatitis E virus?

Authors:  Mohamed T Shata; Udayakumar Navaneethan
Journal:  Clin Infect Dis       Date:  2008-10-15       Impact factor: 9.079

4.  Sporadic acute hepatitis E occurred constantly during the last decade in northeast Japan.

Authors:  Jun Inoue; Yoshiyuki Ueno; Futoshi Nagasaki; Takehiro Akahane; Koji Fukushima; Takayuki Kogure; Yasuteru Kondo; Eiji Kakazu; Keiichi Tamai; Osamu Kido; Yu Nakagome; Masashi Ninomiya; Noriyuki Obara; Yuta Wakui; Masaharu Takahashi; Hiroaki Okamoto; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2009-03-07       Impact factor: 7.527

5.  Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  Mark H Kuniholm; Robert H Purcell; Geraldine M McQuillan; Ronald E Engle; Annemarie Wasley; Kenrad E Nelson
Journal:  J Infect Dis       Date:  2009-07-01       Impact factor: 5.226

6.  Hepatitis E: a complex and global disease.

Authors:  E Pelosi; I Clarke
Journal:  Emerg Health Threats J       Date:  2008-11-07

7.  Hepatitis E virus infection in central China reveals no evidence of cross-species transmission between human and swine in this area.

Authors:  Wen Zhang; Shixing Yang; Liping Ren; Quan Shen; Li Cui; Kezhang Fan; Fen Huang; Yanjun Kang; Tongling Shan; Jianzhong Wei; Haifeng Xiu; Yifang Lou; Junfeng Liu; Zhibiao Yang; Jianguo Zhu; Xiuguo Hua
Journal:  PLoS One       Date:  2009-12-07       Impact factor: 3.240

8.  Virulent strain of hepatitis E virus genotype 3, Japan.

Authors:  Kazuaki Takahashi; Hiroaki Okamoto; Natsumi Abe; Manri Kawakami; Hiroyuki Matsuda; Satoshi Mochida; Hiroshi Sakugawa; Yoshiki Suginoshita; Seishiro Watanabe; Kazuhide Yamamoto; Yuzo Miyakawa; Shunji Mishiro
Journal:  Emerg Infect Dis       Date:  2009-05       Impact factor: 6.883

9.  Seroprevalence of Hepatitis E Virus Infection among Swine Farmers and the General Population in Rural Taiwan.

Authors:  Jian-Te Lee; Pei-Lan Shao; Luan-Yin Chang; Ning-Shao Xia; Pei-Jer Chen; Chun-Yi Lu; Li-Min Huang
Journal:  PLoS One       Date:  2013-06-26       Impact factor: 3.240

10.  Hepatitis E virus seroprevalence in pregnant women in Jiangsu, China, and postpartum evolution during six years.

Authors:  Guangyu Gu; Hongyu Huang; Le Zhang; Yongchun Bi; Yali Hu; Yi-Hua Zhou
Journal:  BMC Infect Dis       Date:  2015-12-09       Impact factor: 3.090
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.